$10.48
-0.63-5.67%
Last update: Nov 4, 7:56 PM
ADMA Biologics Inc
ADMANASDAQ
The average analyst price target for ADMA Biologics is $23.25, 73.0% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $17 to $32. The latest change came on Jul 15, 2026, when Mizuho lowered its price target on ADMA Biologics from $20 to $17 and kept an Outperform rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
